From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA extends review for Pfizer arthritis drug by 3 months

from Reuters

The U.S. Food and Drug Administration extended by three months its review of Pfizer's experimental rheumatoid arthritis treatment tofacitinib, one of the most promising new drugs in the company's pipeline. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063